Breaking the ocular barrier through nano-lipid carriers to treat intraocular diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breaking the ocular barrier through nano-lipid carriers to treat intraocular diseases

Published:2023-09 Issue: Volume:87 Page:104867
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Giri Saumyakanti,Badwaik Hemant^ORCID,Giri Tapan Kumar^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference153 articles.

1. World Report on Vision,2019

2. Solid lipid nanoparticles for ocular drug delivery;Ali;Drug Deliv.,2010

3. Nanoparticles for drug delivery to the anterior segment of the eye;Janagam;Adv. Drug Deliv. Rev.,2017

4. Nanotechnology-based strategies for the treatment of ocular disease;Weng;Acta Pharm. Sin. B,2017

5. Nanotherapies for the treatment of ocular diseases;Reimondez-Troitiño;Eur. J. Pharm. Biopharm.,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing ocular drug delivery challenges with solid nanofiber variants and supramolecular nanofibrous gel composite;Journal of Drug Delivery Science and Technology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP